COVID and brain fog.
For millions, it’s the most disabling legacy of the pandemic.
Now, a new brain imaging study reveals a clear biological basis - and the parallels with other diseases are not encouraging.🧵
Researchers used PET scans with a tracer ([11C]K-2) that binds to AMPA receptors - the tiny gates that neurons use to fire signals via glutamate, the brain’s main excitatory messenger.
These receptors are crucial for learning, memory, and attention.
In people with cognitive long COVID, AMPA receptors weren’t just slightly higher in one region.
They were globally increased across the entire brain!
It’s like the brain’s excitatory volume knob was turned way up everywhere.
That doesn’t mean sharper thinking.
Too many receptors - too much firing - neurons overwhelmed with noise.
Instead of clarity, the brain drowns in signals.
And that feels exactly like brain fog.
The data confirmed it -
The higher the AMPA receptor signal, the worse people performed on tests of visual memory and word-finding.
The biology matches the symptom.
The PET signal also lined up with immune markers -
TNFSF12 up (a pro-inflammatory cytokine)
CCL2 down (a chemokine that normally regulates inflammation)
This suggests inflammation is literally pushing AMPA receptors onto neurons, driving hyper-excitation.
Put this together with earlier findings - reduced glucose metabolism (FDG-PET) and neuroinflammation - and a chain emerges -
Inflammation - astrocyte dysfunction - disrupted glutamate balance - more AMPA receptors - cognitive dysfunction.
Why does this matter?
Because it turns brain fog into something objectively measurable.
Not mood. Not imagination.
A molecular abnormality visible on a brain scan.
Does this mean neurons are already dying?
We don’t know - because this study did not examine that.
It only shows receptor changes, not structural loss.
But in other diseases, chronic AMPA overdrive does lead to neuron death. That’s why the parallels matter.
Yes - increased AMPA receptors can lead to neuronal damage and death - if they persist long-term and are not balanced by inhibitory mechanisms.
Parallels -
Alzheimer’s, Huntington’s, epilepsy - glutamate overactivation - excitotoxic stress - gradual neuron loss.
MS, depression -
cytokines like TNF-α increase AMPAR trafficking - imbalance - cognitive problems.
EBV, ME/CFS -
post-infectious brain fog linked to glutamate dysregulation.
HIV brain disease -
viral proteins disrupt glutamate homeostasis, reshaping synapses.
What does that mean for long COVID?
It may be partly reversible - if inflammation settles and receptor levels normalize, cognition can improve (though often not fully).
Or it may be progressive - if excitotoxic stress continues, leading over months or years to neuron loss and brain atrophy.
We don’t yet know which path dominates.
Is there hope?
Yes - small.
Drugs like perampanel (an AMPA receptor antagonist) are already used in epilepsy.
But - this study did not test treatments.
Whether dampening AMPA activity helps in long COVID is only a hypothesis - not a proven therapy.
So, Long COVID brain fog is not vague or subjective.
It’s a measurable synaptic disorder - an overexcited brain struggling to process information.
It may resolve. Or it may progress.
Either way - it’s real, biological, and must not be dismissed.
This study is pioneering because it showed a molecular abnormality in the living human brain.
But it’s still a pilot with limitations - confirmation through larger cohorts, longitudinal follow-up, and therapeutic trials is still ahead of us.
Caveats.
Only 30 patients, single-center (Japan).
Cross-sectional - a snapshot, not longitudinal.
PET shows receptor density, not neuron count or brain volume.
Confounders - reinfections, vacc, meds, sleep, metabolism.
Causality remains unclear.
Fujimoto at al., Systemic increase of AMPA receptors associated with cognitive impairment of long COVID. Brain Communications, 2025. academic.oup.com/braincomms/art…
This is the strongest evidence yet that ignoring the chronic impacts of COVID in children carries population-level consequences.
A massive Lancet Infect Dis study of >465,000 kids shows:
Reinfections double the risk of long COVID.🧵
After the first infection: about 903 cases of long COVID per million children (within 6 months).
After the second infection: ~1884 cases per million.
That’s more than double the risk (RR = 2.08).
And it’s not just fatigue. Reinfection raised risks across many systems-
myocarditis (RR 3.6),
arrhythmias,
blood clots
kidney injury,
electrolyte issues,
liver enzyme spikes
brain fog, headaches, POTS
anxiety, depression, exhaustion
This preprint shows how SARS-CoV-2 acts like a biological hacker - taking over our protein factories and silencing immune defenses.
It’s not just a respiratory infection. The virus reprograms the fundamental machinery of the cell - and that’s why its impact can linger.🧵
Remember when we learned Nsp1 alone could sabotage ribosomes? Yerlici et al., 2024.
The new preprint reveals SARS-CoV-2 goes even further - broadly reprograms translation to favor viral RNAs + silences immunity.
The main target: translation - the process where ribosomes build proteins from mRNA.
SARS-CoV-2 doesn’t just use it - it reprograms it, so instead of making protective proteins, the cell prioritizes viral ones.
New peer-reviewed study on the chronicity of COVID-19 in Viruses.
One of the authors? Former CDC director Robert Redfield.
The paper warns about persistence of SARS-CoV-2 in Long COVID - and doesn’t shy away from controversy.🧵
LC (PASC) = debilitating chronic disease.
10–20M in the US, >420M globally
200 symptoms, hitting 12 organ systems
No approved treatments
Affects kids, adolescents, healthy adults
Key message.
“Knowledge about chronic LC is still in its embryonic stage.”
Currently, there are more questions than answers.
A study just tested whether an old HIV drug - tenofovir (TDF/TAF) - could work against SARS-CoV-2 and even help with long COVID.
The lab results are striking: it strongly blocked the virus🧵
Tenofovir is a nucleotide analog - a fake building block for viral RNA.
Once inserted, it stops the virus from copying itself.
In experiments, this worked even at high viral loads.
The spotlight is on TAF.
More potent than TDF,
safer for long-term use,
and most importantly - it concentrates in lymphoid tissues (lymph nodes, spleen, immune cells).
A new 3-year follow-up study in Brain Communications tracked patients with post-COVID brain condition for 38 months.
What they found is a story of part compensation, part healing in the brain.🧵
At 6 months, people with post-COVID were still very tired.
Thinking was mostly fine, but attention and alertness were weaker.
Brain scans showed the frontal lobes working overtime - the brain was pushing harder to keep up. That’s early compensation.
At 23 months, there was progress, but not a cure.
Fatigue eased for some, others stayed stuck.
The brain started to spread the workload - brainstem, cerebellum, and temporal areas joined in. More networks pitched in to help - a reorganization phase.
One mystery of Long COVID - why immune cells get stuck in a harmful, inflammatory mode.
A new study shows the switch is metabolic - and a single checkpoint can decide whether Th17 cells protect or drive disease.🧵
In both children and adults with Long COVID, we see immune cells stuck in a harmful mode.
Among them - Th17 cells, which can either protect us or drive chronic inflammation.
A new study in Science Signaling, 2025 uncovers why these cells flip - and what keeps them locked in the pathogenic state.
Th17 cells have two faces -
non-pathogenic (protective, balanced),
pathogenic (autoimmune, chronic inflammation).
The critical switch? Cellular metabolism.